Tirosint Pill
RxNorm 1179085

Concept Hierarchy & Relationship Mapping

RxNorm Concept Unique Identifier (RxCUI) 1179085 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: Tirosint Pill.

The following semantic concepts and normalized strings are associated with this clinical entity:

SBDG
Tirosint Pill
AUI:3847879
View

This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.

SBDGPrescribable

Semantic Branded Dose Form Group (SBDG):
Tirosint Pill
(Atom ID: 3847879)

Clinical Status & Identity

Prescribable Status
YES (Active)
Part of the RxNorm Current Prescribable Content subset including all drugs available for prescription in the USA.
Concept Description
Tirosint Pill
Official description of the drug concept as defined in the source vocabulary.
Suppress Flag
N
N: Not suppressible | O: Obsolete | Y: Suppressed by editor | E: Unquantified non-prescribable drug.

Interoperability & Coding

Concept ID (RxCUI)
1179085
RxNorm Unique Identifier for the standardized concept.
Atom ID (RXAUI)
3847879
Unique identifier for this specific name variation (Atom).
Term Type (TTY)
SBDG
Semantic Branded Dose Form Group (Brand Name + Dose Form Group)
Source Code
1179085
The "Most useful" identifier asserted by the original source vocabulary.

Source & Registry Data

Source Name
RxNorm Vocabulary (RXNORM)
The official name and abbreviation for the vocabulary source.
Source Version
20AA_260601F
The specific version of the vocabulary provided by the source.
Update Date
June 01, 2026
The date when this RxNorm data was last updated by the NLM.
License Contact
RxNorm Customer Service, , U.S. National Library of Medicine, 8600 Rockville Pike, , Bethesda, MD, United States, 20894, (888) FIND-NLM, , https://support.nlm.nih.gov/support/create-case/, https://www.nlm.nih.gov/research/umls/rxnorm/
Source licensing contact information.

Technical Attributes & Logic

RXN AVAILABLE STRENGTH
0.013 MG
Available drug strengths listed in the order of ingredients from the drug
RXN AVAILABLE STRENGTH
0.025 MG
Available drug strengths listed in the order of ingredients from the drug
RXN AVAILABLE STRENGTH
0.0375 MG (expressed as levothyroxine sodium)
Available drug strengths listed in the order of ingredients from the drug
RXN AVAILABLE STRENGTH
0.044 MG (expressed as levothyroxine sodium)
Available drug strengths listed in the order of ingredients from the drug
RXN AVAILABLE STRENGTH
0.05 MG
Available drug strengths listed in the order of ingredients from the drug
RXN AVAILABLE STRENGTH
0.0625 MG (expressed as levothyroxine sodium)
Available drug strengths listed in the order of ingredients from the drug
RXN AVAILABLE STRENGTH
0.075 MG
Available drug strengths listed in the order of ingredients from the drug
RXN AVAILABLE STRENGTH
0.088 MG
Available drug strengths listed in the order of ingredients from the drug
RXN AVAILABLE STRENGTH
0.112 MG
Available drug strengths listed in the order of ingredients from the drug
RXN AVAILABLE STRENGTH
0.125 MG
Available drug strengths listed in the order of ingredients from the drug
RXN AVAILABLE STRENGTH
0.137 MG
Available drug strengths listed in the order of ingredients from the drug
RXN AVAILABLE STRENGTH
0.15 MG
Available drug strengths listed in the order of ingredients from the drug
RXN AVAILABLE STRENGTH
0.175 MG
Available drug strengths listed in the order of ingredients from the drug
RXN AVAILABLE STRENGTH
0.1 MG
Available drug strengths listed in the order of ingredients from the drug
RXN AVAILABLE STRENGTH
0.2 MG
Available drug strengths listed in the order of ingredients from the drug